Form 4: Align Technology Director Mojdeh Poul Equity Update

Director Mojdeh Poul acquired 1,745 shares of Align Technology common stock through the vesting of restricted stock units.

Summary

• Director Mojdeh Poul acquired 1,745 shares of Align Technology (ALGN) common stock on May 20, 2026, following the vesting of restricted stock units (RSUs).
• The reporting person was granted an additional 1,836 RSUs on May 20, 2026, which are scheduled to vest on May 20, 2027, or the date of the next annual meeting of stockholders.
• Following these transactions, the director holds a total of 3,553 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation.

Positives

• The director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• None identified; this is a routine equity compensation disclosure.

Risks

• None identified; this is a standard regulatory filing regarding director compensation.

Future Outlook

The director received a new grant of 1,836 RSUs that will vest on May 20, 2027, or the next annual meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that routine equity grants to directors are standard corporate governance practices in the medical technology sector to ensure long-term alignment between leadership and shareholder value.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard practices for S&P 500 companies.
• The use of RSU vesting schedules is a common retention tool for board members in the healthcare equipment industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of 1,836 RSUs on May 20, 2027.

Key Dates

Keywords

Align Technology, ALGN, Form 4, Insider Trading, Director Compensation, Restricted Stock Units